Abstract
Abstract LPS, present in gram-negative bacteria membranes, causes a strong immune cell activation following detection by TLR4, which initiates a pro-inflammatory cytokine storm that leads to a more severe immunopathology, like septic shock and, subsequently, death. Recently, the myeloid-specific Cd300b receptor was implicated in regulating the immune response to bacterial infection by an unknown mechanism. Here, we identified LPS as a ligand for Cd300b and found that wild-type (WT) mice, unlike Cd300b−/− mice, were highly susceptible to septic shock. WT but not Cd300b−/− mice show increased serum levels of pro-inflammatory cytokines (e.g. TNFa) and a reduced level of the anti-inflammatory cytokine, IL-10. Neutralization of IL-10 in Cd300b−/− mice diminishes their survival advantage over WT mice. In vivo depletion and adoptive transfer studies identify Cd300b-expressing macrophages as the key cell type augmenting septic shock, suggesting that Cd300b amplifies the TLR4-LPS induced immune response thereby causing lethal inflammation. Indeed, Cd300b and its adaptor, DAP12, associated with TLR4/CD14 upon LPS binding, promoting MyD88/TIRAP dissociation and the recruitment and activation of Syk and PI3K. This results in the activation of AKT, which subsequently leads to a reduced IL-10 production, via a PI3K/AKT-dependent inhibition of the MEK1/2-ERK1/2 signaling pathway. In sum, these findings describe a previously unidentified LPS-induced signaling complex consisting of Cd300b/DAP12/TLR4/CD14/Syk/PI3K that effectively amplifies TLR4/CD14-mediated inflammation. Furthermore, our data change the paradigm of how LPS mediates TLR4 signaling in myeloid cells and identify potential targets for future clinical intervention.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have